Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage triggered by hydroxyzine pamoate

Clin Neurol Neurosurg. 2013 Oct;115(10):2189-91. doi: 10.1016/j.clineuro.2013.05.022. Epub 2013 Jun 13.
No abstract available

Keywords: 3.0T magnetic resonance imaging; CBF; CT; CTA; FLAIR; Hydroxyzine; IMP; MRA; MRI; N-isopropyl[123I]-p-iodoamphetamine; RCVS; Reversible cerebral vasoconstriction syndrome; SAH; SPECT; Single photon emission computed tomography; Subarachnoid hemorrhage; cerebral blood flow; computed tomography; computed tomography angiography; fluid-attenuated inversion recovery; magnetic resonance angiography; magnetic resonance imaging; reversible cerebral vasoconstriction syndrome; single photon emission computed tomography; subarachnoid hemorrhage.

Publication types

  • Case Reports

MeSH terms

  • Cerebral Angiography
  • Cerebrovascular Disorders / chemically induced*
  • Cerebrovascular Disorders / diagnostic imaging
  • Cerebrovascular Disorders / etiology*
  • Drug Eruptions / complications
  • Drug Eruptions / drug therapy
  • Female
  • Histamine H1 Antagonists / adverse effects*
  • Histamine H1 Antagonists / therapeutic use
  • Humans
  • Hydroxyzine / adverse effects*
  • Hydroxyzine / therapeutic use
  • Image Processing, Computer-Assisted
  • Iofetamine
  • Magnetic Resonance Angiography
  • Magnetic Resonance Imaging
  • Middle Aged
  • Radiopharmaceuticals
  • Subarachnoid Hemorrhage / chemically induced*
  • Subarachnoid Hemorrhage / complications*
  • Subarachnoid Hemorrhage / diagnostic imaging
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed
  • Vasoconstriction*

Substances

  • Histamine H1 Antagonists
  • Radiopharmaceuticals
  • Hydroxyzine
  • Iofetamine